Quilter PLC Cellectar Biosciences, Inc. Transaction History

Quilter PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.1 - $10.2 $103,761 - $173,502	-17,010 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$11.8 - $18.2 $200,718 - $309,582	17,010 New	17,010 $20,000
Q4 2020 Feb 12, 2021	SELL	$11.2 - $27.7 $650,742 - $1.61 Million	-58,102 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$10.6 - $16.6 $837,442 - $1.31 Million	-79,004 Reduced 57.62%	58,102 $72,000
Q2 2020 Aug 12, 2020	BUY	$10.3 - $17.3 $1.41 Million - $2.37 Million	137,106 New	137,106 $175,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $12.5M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.